ArticleRSC advances2022

Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors.

Sjors van Klaveren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.